Gallant is a new and unique regenerative medicine business focusing on helping pets have better, higher-quality lives.
Working everyday to advance the field of stem cell therapy to transform the field of veterinary medicine. Building the worlds premier platform for regenerative medicine in animal health, Gallant has generated a pipeline of allogeneic products for four indications. In addition to tradition cell therapy platform, Gallant also has early stage cell therapy platform of "primed" cells that are programmed to drive them toward specific effectiveness outcomes.
Partnering with veterinarians and pet parents, Gallant also has the ability to collect and bank young stem cells from the reproductive tissue which would otherwise be discarded during a spay/neuter. These young, potent stem cells are stored for the future when distinct therapies are needed.
Gallant opens a new world of wellness opportunity and makes proven regenerative medicine accessible to pets, pet parents and veterinarians.
Working everyday to advance the field of stem cell therapy to transform the field of veterinary medicine. Building the worlds premier platform for regenerative medicine in animal health, Gallant has generated a pipeline of allogeneic products for four indications. In addition to tradition cell therapy platform, Gallant also has early stage cell therapy platform of "primed" cells that are programmed to drive them toward specific effectiveness outcomes.
Partnering with veterinarians and pet parents, Gallant also has the ability to collect and bank young stem cells from the reproductive tissue which would otherwise be discarded during a spay/neuter. These young, potent stem cells are stored for the future when distinct therapies are needed.
Gallant opens a new world of wellness opportunity and makes proven regenerative medicine accessible to pets, pet parents and veterinarians.
Location: United States, California, San Diego
Employees: 11-50
Total raised: $15M
Founded date: 2018
Investors 1
| Date | Name | Website |
| - | 2Future | 2futurehol... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 09.01.2024 | Series A | $15M | - |
Mentions in press and media 8
| Date | Title | Description |
| 09.01.2024 | Gallant Therapeutics completes a $15M Series A round to boost the development of its pipeline | - |
| 08.01.2024 | Gallant Therapeutics Raises Over $15 Million in Series A Funding to Advance Pipeline of "Off-the-Shelf" Stem Cell Therapies for Pets | - |
| 08.01.2024 | Gallant Therapeutics Raises Over $15M in Series A Funding | Gallant Therapeutics, a San Diego, CA-based animal health biotechnology company pioneering off-the-shelf stem cell therapies for pets, closed its Series A financing, securing over $15m. The round was led by BOLD Capital and joined by new in... |
| 08.01.2024 | Gallant Therapeutics Inks Over $15M in Series A | SAN DIEGO, CA, Gallant Therapeutics, an animal health biotechnology company has raised a Series A financing, securing over $15 million. >> Click here for more funding data on Gallant Therapeutics >> To export Gallant Therape... |
| 08.01.2024 | Gallant Therapeutics Raises Over $15 Million in Series A Funding to Advance Pipeline of "Off-the-Shelf" Stem Cell Therapies for Pets | Leading Investors BOLD Capital, Digitalis Ventures, and Hill Creek Partners drive financial milestone Financing to expedite conditional FDA approval of lead candidate and derisk therapeutic platform for accelerated market access SAN DIEGO, ... |
| - | Gallant Therapeutics: Animal Health Biotech Company Secures Over $15 Million | Gallant Therapeutics – an animal health biotechnology company pioneering off-the-shelf stem cell therapies for pets – recently announced the successful completion of its Series A financing, securing over $15 million. The funding round – whi... |
| - | Gallant Therapeutics | “At Gallant, we're pioneering stem cell therapies and regenerative medicine for pets” |
| - | Gallant Therapeutics | “The future of regenerative medicine for pets” |